| A. Menarini GmbH - Ranexa 750 mg, Retardtabletten | | 60533 | | 03 | | Ranexa 750 mg | | Retardtabletten | | C01EB18 | | Ranolazine | | 13.04.2010 | | |
| | Composition | | ranolazinum 750 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 2.29 mg, Überzug: triacetinum, hypromellosum, lactosum monohydricum 12 mg, cera carnauba, E 171, E 102 40 µg, E 133, pro compresso obducto. | | Packungsbestandteile | | Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Ranolazinum | 750 mg |
| | BAG: Active Agent | Dose |
|---|
| Ranolazinum | 750 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Acidi Methacrylici | | | | Cellulosum Microcristallinum | | | | Cera Carnauba | | | | E 102 | 40 µg | color. | | E 133 | | color. | | E 171 | | color. | | Hypromellosum | | | | Lactose Monohydrate | 12 mg | | | Magnesii Stearas | | | | Methylis Methacrylatis Polymerisatum | | | | Sodium Hydroxide | | | | Pro Compresso Obducto | | | | Triacetinum | | Überzug |
| |
| |
|
